Taiwanese Medical Societies Issue Joint Guidelines for MASLD and Obesity Management, Highlighting GLP-1 Agonists
Taiwan GEST-TASL-TMASO Joint Position Statement in Managing Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity.
Abstract
Taiwanese medical societies released joint guidelines for MASLD and obesity management, recommending a multidisciplinary approach including GLP-1 receptor agonists, resmetirom, and bariatric surgery.
